These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10396518)

  • 1. Combined oral contraceptives, smoking, and cardiovascular risk.
    Farley TM; Meirik O; Chang CL; Poulter NR
    J Epidemiol Community Health; 1998 Dec; 52(12):775-85. PubMed ID: 10396518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal contraception and risk of cardiovascular disease. An international perspective.
    Farley TM; Collins J; Schlesselman JJ
    Contraception; 1998 Mar; 57(3):211-30. PubMed ID: 9617537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks.
    Farley TM; Meirik O; Collins J
    Hum Reprod Update; 1999; 5(6):721-35. PubMed ID: 10652981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
    Schwingl PJ; Shelton J
    Contraception; 1997 Mar; 55(3):125-9. PubMed ID: 9114999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):505-10. PubMed ID: 8757152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern oral contraceptives and cardiovascular disease.
    Rosenberg L; Palmer JR; Sands MI; Grimes D; Bergman U; Daling J; Mills A
    Am J Obstet Gynecol; 1997 Sep; 177(3):707-15. PubMed ID: 9322646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic diseases in young women and the influence of oral contraceptives.
    Lidegaard O
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined oral contraceptives: risks and benefits.
    Thorogood M; Villard-Mackintosh L
    Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
    Dunn N; Thorogood M; Faragher B; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R
    BMJ; 1999 Jun; 318(7198):1579-83. PubMed ID: 10364115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of oral contraceptives and cardiovascular disease.
    Chasan-Taber L; Stampfer MJ
    Ann Intern Med; 1998 Mar; 128(6):467-77. PubMed ID: 9499331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):498-505. PubMed ID: 8757151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
    BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.